Antonio Francesco Di Naro (born in 1966) is Chairman and President. He holds a doctor in chemistry and pharmaceutical technologies and developed two transplantation products (Thymoglobuline and Celsior). He has more than 20 years’ experience in the development of orphan drugs from reasearch to commercialization

 Research and development, Clinical trials, Clinical research, Clinical scientist, Clinical science